TNSN99227A1 - Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
TNSN99227A1
TNSN99227A1 TNTNSN99227A TNSN99227A TNSN99227A1 TN SN99227 A1 TNSN99227 A1 TN SN99227A1 TN TNSN99227 A TNTNSN99227 A TN TNSN99227A TN SN99227 A TNSN99227 A TN SN99227A TN SN99227 A1 TNSN99227 A1 TN SN99227A1
Authority
TN
Tunisia
Prior art keywords
pharmaceutical compositions
compositions containing
compounds
formula
preparation
Prior art date
Application number
TNTNSN99227A
Other languages
English (en)
Inventor
Kaneko Takushi
Su Wei-Guo
Wu Yong-Jin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN99227A1 publication Critical patent/TNSN99227A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'INVENTION CONCERNE DES COMPOSES DE FORMULE 1 : DANS LAQUELLE X1, X2, R2, R15, R16 ET R6 REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE EGALEMENT UN PROCEDE POUR LEUR PREPARATION ET DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. APPLICATION : UTILISATION DE CES COMPOSES ET COMPOSITIONS POUR LE TRAITEMENT D'INFECTIONS BACTERIENNES ET D'INFECTIONS PAR DES PROTOZOAIRES
TNTNSN99227A 1998-12-10 1999-12-02 Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant TNSN99227A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11172898P 1998-12-10 1998-12-10

Publications (1)

Publication Number Publication Date
TNSN99227A1 true TNSN99227A1 (fr) 2005-11-10

Family

ID=22340138

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99227A TNSN99227A1 (fr) 1998-12-10 1999-12-02 Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (13)

Country Link
US (1) US6664238B1 (fr)
EP (1) EP1137654A1 (fr)
AT (1) ATE344269T1 (fr)
AU (1) AU6484199A (fr)
DE (1) DE69933897T2 (fr)
ES (1) ES2273964T3 (fr)
GT (1) GT199900208A (fr)
MA (1) MA26711A1 (fr)
PA (1) PA8486401A1 (fr)
PE (1) PE20001297A1 (fr)
TN (1) TNSN99227A1 (fr)
TR (1) TR200102129T2 (fr)
WO (1) WO2000034297A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000017218A1 (fr) 1998-09-22 2000-03-30 Pfizer Products Inc. Antibiotiques carbamates et carbazates cetolides
HUP0105190A3 (en) * 1999-01-27 2003-03-28 Pfizer Prod Inc Ketolide antibiotics, medicaments containing them and their use
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
KR100710605B1 (ko) 1999-04-16 2007-04-24 코산 바이오사이언시즈, 인코포레이티드 매크롤라이드 항감염제
IL145976A0 (en) 1999-04-16 2002-07-25 Ortho Mcneil Pharm Inc Ketolide antibacterials
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
KR100924610B1 (ko) * 2004-12-07 2009-11-02 이난타 파마슈티칼스, 인코포레이티드 3,6-비시클롤리드
EP2233493A1 (fr) * 2004-12-21 2010-09-29 Pfizer Products Inc. Macrolides
CN1318441C (zh) * 2005-04-25 2007-05-30 中国医学科学院医药生物技术研究所 大环内酯类抗生素的酮内酯化合物及其制备方法和用途
WO2007060518A2 (fr) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Dérivés de cétolide en tant qu'agents antibactériens
WO2009055557A1 (fr) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Procédé pour la préparation d'agents antibactériens macrolides
US8796232B2 (en) 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
WO2011119604A1 (fr) 2010-03-22 2011-09-29 Cempra Pharmaceuticals, Inc. Formes cristallines d'un macrolide et leurs utilisations
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20180110181A (ko) 2010-09-10 2018-10-08 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
CA2868262A1 (fr) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Formulations parenterales pour l'administration d'antibiotiques macrolides
CN105163785A (zh) 2013-03-14 2015-12-16 森普拉制药公司 用于治疗呼吸道疾病的方法及其制剂
CA2907085A1 (fr) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Procedes convergents de preparation d'agents antibacteriens macrolides
CN114437154B (zh) * 2022-01-30 2024-03-01 北京理工大学 一种含有喹诺酮的酮内酯衍生物及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
IL114589A (en) 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5527780A (en) 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE19626036A1 (de) 1996-06-28 1998-01-02 Whitaker Corp Optischer Steckverbinder
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CN1238777A (zh) 1996-11-27 1999-12-15 大正制药株式会社 红霉素a衍生物
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US5794778A (en) 1997-02-26 1998-08-18 Riverwood International Corporation Article carrier with strap-type handle and top panel access
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
MA26711A1 (fr) 2004-12-20
PA8486401A1 (es) 2003-01-24
WO2000034297A1 (fr) 2000-06-15
ATE344269T1 (de) 2006-11-15
GT199900208A (es) 2001-05-31
DE69933897T2 (de) 2007-03-15
ES2273964T3 (es) 2007-05-16
TR200102129T2 (tr) 2002-01-21
DE69933897D1 (de) 2006-12-14
EP1137654A1 (fr) 2001-10-04
AU6484199A (en) 2000-06-26
US6664238B1 (en) 2003-12-16
PE20001297A1 (es) 2000-12-04

Similar Documents

Publication Publication Date Title
MA26711A1 (fr) Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
EA200100623A1 (ru) Кетолидные антибиотики
TNSN99161A1 (fr) Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2292359A1 (fr) Nouveaux azalides et procede de fabrication
EA199901014A1 (ru) C-4"-замещенные макролидные производные
EA200100396A1 (ru) Новые макролидные антибиотики
EP0941998A3 (fr) Antibiotiques macrolides de type 3,6-cétal et éther d'énol
EA200400701A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
ATE260928T1 (de) Ketolidantibiotika
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
EA200001029A1 (ru) Производные гигромицина
ATE271062T1 (de) Makrolid-antibiotika
EA200001028A1 (ru) Производные 2"-деоксигигромицина
EA200100444A1 (ru) Производные гигромицина а в качестве антибактериальных агентов
EA200201167A1 (ru) Производные гигромицина а для лечения бактериальных и протозойных инфекций